Table 2.
High risk | Moderate risk | Low risk | |
---|---|---|---|
Degree of immunosuppression | High level of immunosuppression: • Within initial 6 months post-kidney transplant • Undergoing treatment for acute rejection (high-dose steroids, thymoglobulin, rituximab) |
Stable and tapering level of immunosuppression: • Within 6-12 months post-kidney transplant • Within 3-6 months post-treatment for acute rejection OR Increased level of immunosuppression (ie, for treatment of donor-specific antibodies) |
Stable and low level of immunosuppression: • Beyond 1st year post-transplant on low baseline immunosuppression • Beyond 6 months post-treatment for acute rejection |
Medical stability | Unstable allograft function with increased likelihood for increasing level of immunosuppression (ie, for acute rejection, donor-specific antibodies) | Stable and improving allograft function, on tapering level of immunosuppression Low likelihood for need to increase level of immunosuppression |
Stable allograft function |
Comorbidities | Unstable, multiple, or severe comorbidities: • Obesity • Diabetes mellitus • Chronic lung or cardiac disease • Neurologic and neurodevelopmental conditions • Rheumatologic diseases • Inflammatory bowel disease • Inherited metabolic disorders • Hematologic disorders • Severe liver diseases • Severe kidney diseases Concurrent immunocompromising condition (ie, treatment of malignancy/PTLD, primary immunodeficiency) Conditions suggesting increased net state of immunosuppressed state (ie, lymphopenia, concomitant CMV) |
Stable or improving stability of comorbidities | No comorbidities |
Ability to adhere to enhanced precautions in school | Unable to consistently adhere to optimal physical distancing, frequent hand hygiene practices, and/or wearing face covering | Unable to consistently adhere to optimal physical distancing, frequent hand hygiene practices, or wearing a face covering BUT otherwise considered “low risk” | Able to consistently adhere to optimal physical distancing, frequent hand hygiene practices, and wearing a face covering |
Local COVID-19 activitya | High level of active community spread | Moderate level of active community spread | Stable and low level of active community spread |
Note. COVID-19 risk stratification for pediatric kidney transplant recipients based on risk factors for severe COVID-19 in adults, emerging risk factors for severe COVID-19 in children, and extrapolation of risk factors from other respiratory viruses. CMV = cytomegalovirus.
Degree of COVID-19 activity (high, moderate, low) as defined by local public health authorities.